Beacon Capital Management, LLC Sarepta Therapeutics, Inc. Transaction History

Beacon Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	SELL	$63.82 - $127.89 $22,592 - $45,273	-354 Reduced 87.84%	49 $3,000
Q1 2023 Apr 20, 2023	SELL	$117.53 - $155.99 $17,511 - $23,242	-149 Reduced 26.99%	403 $55,000
Q4 2022 Jan 27, 2023	SELL	$100.86 - $132.13 $8,976 - $11,759	-89 Reduced 13.88%	552 $0
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $40,479 - $57,959	641 New	641 $50,000

407

83.7M

5.27M

5.94M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Beacon Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Capital Management, LLC with notifications on news.